TATA健康(01255.HK)发2024年度业绩：股东应占亏损6833.8万港元 同比扩大111.6%

Core Insights - TATA Health (01255.HK) reported a revenue of HKD 124 million for the fiscal year ending December 31, 2024, representing a 40% year-on-year decline [1] - The company recorded a loss attributable to shareholders of HKD 68.34 million, which is an increase of 111.6% compared to the previous year [1] - Basic loss per share was HKD 0.28 [1] Revenue Analysis - The decline in revenue is primarily attributed to a decrease in the footwear business [1] - The challenging economic environment has led to weakened consumer sentiment, significantly impacting the retail sector in Hong Kong [1]